News analysis / Americas

FDA told it should abandon deeming regs, turn to Congress

10th August 2014 | News analysis |

The U.S. Food and Drug Administration (FDA) is likely to have received a deluge of comments in the run-up to the closing of the public consultation period on its e-cigarette regulations last Friday – among them a biting critique of the agency’s approach from a U.S. vapers’ group.

Blu still on top, but faltering; Lorillard remains optimistic

31st July 2014 | News analysis |

Lorillard’s brand Blu retains around a 40% share of the U.S. mainstream retail market for e-cigarettes, an enviable position in many categories. But there are signs in the firm’s latest financial results and in measurement data that its ascendance is slowing, and that if Imperial Tobacco takes over the Blu brand as expected early next year, it will not be inheriting an unstoppable market leader.